• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞和外泌体 microRNAs:作为乳腺癌诊断和预后靶点的临床新关联。

Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis.

机构信息

Department of Nanoengineering, Joint School of Nanoscience and Nanoengineering, North Carolina, A&T State University, 2907 E. Gate City Blvd, Greensboro, NC, 27401, USA.

Department of Nanoscience, Joint School of Nanoscience and Nanoengineering, University of North Carolina, 2904 E. Gate City Blvd, Greensboro, NC, 27401, USA.

出版信息

Adv Biol (Weinh). 2024 Apr;8(4):e2300532. doi: 10.1002/adbi.202300532. Epub 2024 Jan 22.

DOI:10.1002/adbi.202300532
PMID:38258348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11198028/
Abstract

Breast cancer accounts for the highest cancer cases globally, with 12% of occurrences progressing to metastatic breast cancer with a low survival rate and limited effective early intervention strategies augmented by late diagnosis. Moreover, a low concentration of prognostic and predictive markers hinders disease monitoring. Circulating and exosomal microRNAs (miRNAs) have recently shown a considerable interplay in breast cancer, standing out as effective diagnostic and prognostic markers. The primary functions are as gene regulatory agents at the genetic and epigenetic levels. An array of dysregulated miRNAs stimulates cancer-promoting mechanisms, activating oncogenes and controlling tumor-suppressing genes and mechanisms. Exosomes are vastly studied extracellular vesicles, carrying, and transporting cargo, including noncoding RNAs with premier roles in oncogenesis. Translocation of miRNAs from the circulation to exosomes, with RNA-binding proteins in stress-induced conditions, has shown significant cooperation in function to promote breast cancer. This review examines cellular and exosomal miRNA biogenesis and loading, the clinical implications of their dysregulation, their function in diagnosis, prognosis, and prediction of breast cancer, and in regulating cancer signaling pathways. The influence of cellular and exosomal miRNAs presents clinical significance on breast cancer diagnosis, subtyping, staging, prediction, and disease monitoring during treatment, hence a potent marker for breast cancer.

摘要

乳腺癌是全球发病率最高的癌症,其中 12%的病例进展为转移性乳腺癌,存活率低,且早期诊断时有效的干预策略有限。此外,由于预后和预测标志物的浓度较低,疾病监测受到阻碍。循环和外泌体 microRNAs(miRNAs)最近在乳腺癌中表现出相当大的相互作用,成为有效的诊断和预后标志物。其主要功能是作为遗传和表观遗传水平的基因调控因子。一系列失调的 miRNAs 刺激促进癌症的机制,激活癌基因并控制肿瘤抑制基因和机制。外泌体是广泛研究的细胞外囊泡,携带和转运 cargo,包括在致癌作用中起主要作用的非编码 RNA。在应激诱导条件下,miRNA 从循环转移到外泌体,并与 RNA 结合蛋白合作,在功能上具有显著的协同作用,促进乳腺癌的发生。这篇综述检查了细胞和外泌体 miRNA 的生物发生和加载,其失调的临床意义,它们在乳腺癌诊断、预后和预测中的功能,以及在调节癌症信号通路中的功能。细胞和外泌体 miRNAs 的影响在乳腺癌的诊断、亚型、分期、预测和治疗期间的疾病监测方面具有临床意义,因此是乳腺癌的一个有力标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/edb7b1724e3b/nihms-1959934-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/50b0efe78a70/nihms-1959934-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/bf03c8afa3ac/nihms-1959934-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/60cd24e053e0/nihms-1959934-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/edb7b1724e3b/nihms-1959934-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/50b0efe78a70/nihms-1959934-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/bf03c8afa3ac/nihms-1959934-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/60cd24e053e0/nihms-1959934-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b31/11198028/edb7b1724e3b/nihms-1959934-f0005.jpg

相似文献

1
Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis.细胞和外泌体 microRNAs:作为乳腺癌诊断和预后靶点的临床新关联。
Adv Biol (Weinh). 2024 Apr;8(4):e2300532. doi: 10.1002/adbi.202300532. Epub 2024 Jan 22.
2
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.外泌体 miRNA 谱作为新辅助化疗局部乳腺癌诊断和预测治疗反应的补充工具。
Breast Cancer Res. 2019 Feb 6;21(1):21. doi: 10.1186/s13058-019-1109-0.
3
Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.评估高转移性乳腺癌中靶向 PTEN 和 DUSP14 的外泌体 miR-9 和 miR-155 及其对低转移性细胞的影响。
J Cell Biochem. 2019 Apr;120(4):5666-5676. doi: 10.1002/jcb.27850. Epub 2018 Oct 18.
4
Exosomes and exosomal RNAs in breast cancer: A status update.外泌体及其在乳腺癌中的 RNA :研究进展。
Eur J Cancer. 2021 Feb;144:252-268. doi: 10.1016/j.ejca.2020.11.033. Epub 2020 Dec 26.
5
Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.聚焦乳腺癌中的外泌体非编码 RNA:lncRNA/circRNA-miRNA-靶轴的计算分析。
Int J Mol Sci. 2022 Jul 28;23(15):8351. doi: 10.3390/ijms23158351.
6
The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer.外泌体 microRNAs 在乳腺癌肿瘤微环境中的作用。
Int J Mol Sci. 2019 Aug 9;20(16):3884. doi: 10.3390/ijms20163884.
7
Exosomal microRNA: a novel biomarker for breast cancer.外泌体 microRNA:乳腺癌的一种新型生物标志物。
Biomark Med. 2018 Feb;12(2):177-188. doi: 10.2217/bmm-2017-0305. Epub 2017 Nov 20.
8
Exosomal noncoding RNA (ncRNA) in breast cancer pathogenesis and therapy; two sides of the same coin.外泌体非编码RNA(ncRNA)在乳腺癌发病机制及治疗中的作用:一枚硬币的两面
Exp Cell Res. 2025 Jan 1;444(1):114359. doi: 10.1016/j.yexcr.2024.114359. Epub 2024 Nov 26.
9
Potential roles of the exosome/microRNA axis in breast cancer.外泌体/微小RNA轴在乳腺癌中的潜在作用。
Pathol Res Pract. 2023 Nov;251:154845. doi: 10.1016/j.prp.2023.154845. Epub 2023 Oct 5.
10
Emerging role of exosomes and exosomal microRNA in cancer: pathophysiology and clinical potential.外泌体和外泌体 microRNA 在癌症中的新作用:病理生理学和临床潜力。
J Cancer Res Clin Oncol. 2021 Mar;147(3):637-648. doi: 10.1007/s00432-021-03534-5. Epub 2021 Jan 29.

引用本文的文献

1
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.利用肿瘤微环境:通过调节上皮-间质转化实现靶向癌症治疗
J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6.
2
The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead.纳米医学中细胞外囊泡的潜力:近期进展与未来挑战综述
Adv Biol (Weinh). 2024 Dec 31:e2400623. doi: 10.1002/adbi.202400623.

本文引用的文献

1
Deregulation of miR-375 Inhibits HOXA5 and Promotes Migration, Invasion, and Cell Proliferation in Breast Cancer.miR-375 的去调控抑制 HOXA5 并促进乳腺癌中的迁移、侵袭和细胞增殖。
Appl Biochem Biotechnol. 2023 Jul;195(7):4503-4523. doi: 10.1007/s12010-023-04375-3. Epub 2023 Jan 26.
2
Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression.miR-335 和 miR-145 的启动子异常高甲基化参与乳腺癌 PD-L1 的过表达。
Sci Rep. 2023 Jan 18;13(1):1003. doi: 10.1038/s41598-023-27415-8.
3
Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes.
外泌体 miR-1304-3p 通过激活癌相关脂肪细胞促进非裔美国人乳腺癌的进展。
Nat Commun. 2022 Dec 14;13(1):7734. doi: 10.1038/s41467-022-35305-2.
4
Overcoming the blood-brain barrier: Exosomes as theranostic nanocarriers for precision neuroimaging.克服血脑屏障:外泌体作为精准神经成像的治疗诊断纳米载体。
J Control Release. 2022 Sep;349:902-916. doi: 10.1016/j.jconrel.2022.08.002. Epub 2022 Aug 5.
5
Extracellular vesicles through the blood-brain barrier: a review.细胞外囊泡穿越血脑屏障:综述。
Fluids Barriers CNS. 2022 Jul 25;19(1):60. doi: 10.1186/s12987-022-00359-3.
6
Analysis of Breast Cancer Based on the Dysregulated Network.基于失调网络的乳腺癌分析
Front Genet. 2022 Feb 15;13:856075. doi: 10.3389/fgene.2022.856075. eCollection 2022.
7
The role of Exosomal miRNAs in cancer.外泌体 miRNAs 在癌症中的作用。
J Transl Med. 2022 Jan 3;20(1):6. doi: 10.1186/s12967-021-03215-4.
8
Regulation of the tumor suppressor PTEN in triple-negative breast cancer.三阴性乳腺癌中肿瘤抑制因子 PTEN 的调控。
Cancer Lett. 2022 Feb 28;527:41-48. doi: 10.1016/j.canlet.2021.12.003. Epub 2021 Dec 10.
9
Multiplexed Profiling of Extracellular Vesicles for Biomarker Development.用于生物标志物开发的细胞外囊泡多重分析
Nanomicro Lett. 2021 Dec 2;14(1):3. doi: 10.1007/s40820-021-00753-w.
10
Screening Plasma Exosomal RNAs as Diagnostic Markers for Cervical Cancer: An Analysis of Patients Who Underwent Primary Chemoradiotherapy.筛查血浆外泌体 RNA 作为宫颈癌的诊断标志物:对接受初次放化疗的患者的分析。
Biomolecules. 2021 Nov 14;11(11):1691. doi: 10.3390/biom11111691.